GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Sale Of Investment

Argos Therapeutics (FRA:77AA) Sale Of Investment : €0.00 Mil (TTM As of Sep. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Sale Of Investment?

Argos Therapeutics's sale of investment for the three months ended in Sep. 2018 was €0.00 Mil. It means Argos Therapeutics gained €0.00 Mil from selling investments. Argos Therapeutics's sale of investment for the trailing twelve months (TTM) ended in Sep. 2018 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2018 ), Argos Therapeutics gained the same money from selling investments in Sep. 2018 (€0.00 Mil).


Argos Therapeutics Sale Of Investment Historical Data

The historical data trend for Argos Therapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Sale Of Investment Chart

Argos Therapeutics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only 2.99 16.40 19.00 0.95 -

Argos Therapeutics Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Argos Therapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Argos Therapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Argos Therapeutics (FRA:77AA) Business Description

Traded in Other Exchanges
N/A
Address
4233 Technology Drive, Durham, NC, USA, 27704
Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines